Skip to main content
    B

    Bright Minds Biosciences Inc (DRUG)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $22.61
    -0.50 (-2.16%)

    Market Cap: $227.96M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Bright Minds Biosciences Inc (DRUG) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Bright Minds Biosciences are Palisade Bio (PALI), LENZ Therapeutics (LENZ) and Bicycle Therapeutics (BCYC). By market cap, Bright Minds Biosciences ranks 8th of the 13 companies on this page; X4 Pharmaceuticals (XFOR) is the largest at $318.59M.

    Peer Comparison

    DRUG's ROIC of -11.2% is above the peer median of -36.9%, and its revenue growth of 0.0% is above the median of -24.2%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Bright Minds Biosciences (DRUG)$227.96MN/AN/A0.0%-11.2%0.0%0.00%
    Palisade Bio Inc (PALI)$201.01MN/A436.8x0.0%N/A0.0%0.00%
    LENZ Therapeutics Inc (LENZ)$129.77MN/A9.7x0.0%N/A-72.9%0.00%
    Bicycle Therapeutics Ltd (BCYC)$236.22MN/A2.7x-169.8%N/A190.2%0.00%
    Sutro Biopharma (STRO)$163.03MN/A3.4x0.0%N/A-6.1%0.00%
    Precision BioSciences Inc (DTIL)$288.76MN/A4.4x-85.6%-38.3%37272.0%0.00%
    Immuneering Corp (IMRX)$240.27MN/AN/A0.0%N/A-99.8%0.00%
    Rocket Pharmaceuticals Inc (RCKT)$256.82MN/AN/A0.0%-2.3%0.0%0.00%
    Upstream Bio, Inc. (UPB)$152.38MN/A41.0x0.0%N/A-42.2%0.00%
    Inhibikase Therapeutics Inc (IKT)$213.21MN/AN/A0.0%N/A-100.0%0.00%
    Fulcrum Therapeutics Inc (FULC)$287.96MN/AN/A0.0%N/A-100.0%0.00%
    X4 Pharmaceuticals Inc (XFOR)$318.59MN/A21.7x0.0%-36.9%63.1%0.00%
    Century Therapeutics Inc (IPSC)$299.63MN/AN/A0.0%N/A-100.0%0.00%
    Peer median$238.24MN/A9.7x0.0%-36.9%-24.2%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Bright Minds Biosciences, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Palisade Bio Inc (PALI)
    Leading BioSciences, Inc. develops therapies to improve human health through therapeutic protection of the gastrointestinal mucosal barrier.
    PALI competitors
    LENZ Therapeutics Inc (LENZ)
    LENZ Therapeutics Inc is a cutting-edge biopharmaceutical company dedicated to developing transformative therapies for neurological disorders...
    LENZ competitors
    Bicycle Therapeutics Ltd (BCYC)
    Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, is developing a class of drugs for diseases that are not served by existing treatments.
    BCYC competitors
    Sutro Biopharma (STRO)
    Sutro Biopharma, Inc. is a clinical stage drug discovery, development and manufacturing company.
    STRO competitors
    Precision BioSciences Inc (DTIL)
    Precision BioSciences, Inc., a genome editing company, develops therapeutic products in the United States.
    DTIL competitors
    Immuneering Corp (IMRX)
    Immuneering Corp (IMRX) is a cutting-edge biotechnology firm dedicated to advancing targeted therapeutics for cancer and other critical illnesses through its...
    IMRX competitors
    Rocket Pharmaceuticals Inc (RCKT)
    Rocket Pharmaceuticals, Inc., is a cross-platform biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases.
    RCKT competitors
    Upstream Bio, Inc. (UPB)
    Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders.
    UPB competitors
    Inhibikase Therapeutics Inc (IKT)
    Inhibikase Therapeutics, Inc., a clinical-stage pharmaceutical company, develops therapies for Parkinson's disease (PD) and related disorders that arise inside...
    IKT competitors
    Fulcrum Therapeutics Inc (FULC)
    Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products to improve the lives of patients with genetically defined...
    FULC competitors
    X4 Pharmaceuticals Inc (XFOR)
    X4 Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the research, development...
    XFOR competitors
    Century Therapeutics Inc (IPSC)
    Century Therapeutics Inc. (Ticker: IPSC) is a leading biotechnology company specializing in allogenic cell therapy...
    IPSC competitors

    Frequently Asked Questions About DRUG

    Who are Bright Minds Biosciences' main competitors?

    The companies most similar to Bright Minds Biosciences include Palisade Bio (PALI), LENZ Therapeutics (LENZ), Bicycle Therapeutics (BCYC), Sutro Biopharma (STRO) and Precision BioSciences (DTIL), listed from the closest match.

    Who is Bright Minds Biosciences' biggest competitor?

    X4 Pharmaceuticals (XFOR) is the largest of the similar companies at $318.59M; Palisade Bio (PALI) is the closest match by business profile, size, sector and industry.

    How does DRUG stock compare with its competitors?

    DRUG's net margin is 0.0% against a peer median of 0.0%.

    Which of Bright Minds Biosciences' competitors pays a higher dividend?

    Bright Minds Biosciences pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Bright Minds Biosciences bigger than its competitors?

    No. Bright Minds Biosciences is 8th by market cap among the 13 companies on this page; the largest is X4 Pharmaceuticals (XFOR) at $318.59M.